To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: FDA Approves Methylphenidate HCl Extended-Release Tablets for Treatment of ADHD in Adults URL: http://www.pslgroup.com/dg/22471A.htm Doctor's Guide June 27, 2008
RARITAN, NJ -- June 27, 2008 -- The US Food and Drug Administration (FDA) has approved methylphenidate HCl extended-release tablets (Concerta) for treatment of attention deficit hyperactivity disorder (ADHD) in adults aged 18 to 65 years. The doses approved for adults range from 18 to 72 mg daily.